In this issue of Indian Journal of Gastroenterology, Bhamre et al. have published an article on psychiatric comorbidities in patients with inflammatory bowel disease (IBD) in comparison with healthy controls [1] . They studied 70 patients with IBD (62 with ulcerative colitis and 8 with Crohn's disease) and 100 healthy controls. Patients and controls were administered two (self-administered) tests: Patient Health Questionnaire-9 (PHQ-9) and Symptom Checklist Anxiety Scale (SCL-A20). Individuals with PHQ-9 score > 10 or SCL-A20 score > 29 underwent further testing with depression and anxiety scales and severity of anxiety and depression was graded. The prevalence of depression was 34.3% (healthy controls 5%) and that of anxiety was 18.6% (healthy controls 2%). This is probably the first study on psychiatric comorbidities in patients with IBD from India and shows significant prevalence of psychiatric comorbidities in IBD. This study includes a small number of patients with Crohn's disease, so it would be difficult to generalize the results to patients with Crohn's disease. But it certainly raises an important question-are we not doing the right thing, i.e. screening our IBD patients for psychiatric morbidities?
The relationship between IBD and psychological factors is not new. In fact, in 1930, IBD was considered as a psychosomatic illness. Decades later, pendulum swung the other way and other factors were considered as etiological factors for IBD. IBD, then, was considered only an organic disease and psychological factors were not considered as important. Later, evidence pointed towards the relationship between stress and IBD and the role psychological factors is now better defined [2] . Psychological factors have not been clearly linked to the onset of disease but have been linked to it's course [3] [4] [5] [6] .
Prevalence of psychiatric comorbidities in patients with inflammatory bowel disease
A recent (2016) systematic review by Neuendorf et al.
(171 studies with 158,371 patients) reported the prevalence of anxiety and depression among patients with ulcerative colitis and Crohn's disease. They found pooled prevalence of anxiety symptoms to be 35% and that of anxiety disorder to be 21%. The pooled prevalence of depressive symptoms was 22% and that of depressive disorder 15%. The prevalence of depression was higher in patients with Crohn's disease than ulcerative colitis and higher in patients with active disease [7] .
Surgery marks an important and often worrisome event in the lifetime of patients with IBD. Studies have looked at anxiety and depression in surgical patients. A recent review (2017; 30 studies with 4340 patients) by Zangenberg and El-Hussuna looked at the psychiatric morbidity after IBD-related surgery [8] . Some studies in this review compared post-surgical patients with IBD as compared with the patients undergoing surgery for the other conditions such as diverticulitis and inguinal hernia; they also compared between post-surgical patients with IBD as compared to non-operated IBD patients. This review suggested an increased risk of depression in patients with Crohn's disease and increased risk of anxiety among patients with ulcerative colitis.
Risk factors for psychiatric morbidity
Brooks et al., in a recent systematic review (2016; 30 studies), looked at the risk factors of psychological morbidity in young people (10 to 24 years) with IBD. The risk factors for psychological morbidity included high disease severity, lower socioeconomic status, corticosteroids use, parental stress, and older age at diagnosis [9] . Six studies showed positive correlation between IBD severity and psychiatric illness whereas three studies did not show such a correlation. Three studies showed that lower socioeconomic status was associated with depressive symptoms and two studies did not find any such relationship. Four of five studies suggested relationship between corticosteroids treatment and psychological morbidity. No definite conclusion could be drawn regarding dose of steroids and psychological morbidity. Maternal depression, cohesion and conflict, and affective involvement of the family had relationship with the psychological comorbidity [10, 11] . Older age at diagnosis was associated with more depressive symptoms. Younger age at diagnosis was associated with more somatic symptoms but the use of psychotropic drug did not increase [12, 13] .
Long et al. evaluated the risk factors for depression in elderly (> 65 years) patients with IBD and found that lower education level, higher corticosteroid use, and lower exercise level were associated with depression in these patients [14] .
The other risk factors have been studied. The studies on effect of gender, ethnicity, duration of IBD, and use of immunosuppressive drugs on psychological morbidity have shown mixed results and therefore, no definite conclusion can be drawn.
Impact of psychiatric morbidity on course of disease in patients with inflammatory bowel disease
Brooks et al. found that psychiatric comorbidity in patients with IBD resulted in abdominal pain, poor adherence to medications, sleep disturbances, use of psychotropic drug, and negative illness perception [9] . Patients with Crohn's disease were twice more likely to receive psychotropic drugs than age-, sex-, and health plan enrollmentmatched controls [15] .
Patients with IBD with psychiatric comorbidities have poor health-related quality of life and increased health resource utilization [16] and the disease course is worse in such patients [17] .
Screening for psychiatric comorbidities in patients with IBD
Screening patients for psychiatric morbidities help in improving the quality of life and improves disease course. Bennenbroke et al. suggested that screening for psychiatric symptoms and treatment should be part of management of IBD [17, 18] . If screening is advisable, how should screening is done? Graff et al. have suggested three types of approaches: routinely screen IBD patients for psychological co-morbidity, use brief standardized patient-report or questionnaire as Bhamre et al. have used, or screen with three questions (any difficulties with stress, worry or anxiety, any nervousness, jittery feeling or tensions, feeling of low down or depression) [17] .
Management of psychiatric comorbidities in patient with IBD
Most patients with anxiety and depression do not seek or get proper treatment for psychiatric co-morbidity resulting in disability or more frequent visits to the hospital. The management consists of mainly two types of therapies: pharmacological treatments (anti-anxiety and anti-depressant medications) and non-pharmacolog psychological intervention. These therapies may be combined. These improve psychological symptoms/disorders and may improve the course of IBD and quality of life [2] .
In summary, Bhamre and colleagues have highlighted an important lacuna in management of IBD. Psychiatric comorbidities are prevalent in about a fifth of patients with IBD. They clearly have an impact on various aspects of IBD. Therefore, it can be suggested that all the patients with IBD should be screened for psychiatric co-morbidities. The pharmacological and psychological treatments are effective.
